Alveo Technologies
Alveo Technologies is seeking professionals to help reshape diagnostics for a healthier and more sustainable future. The role involves working on the Alveo Sense platform to enable rapid molecular detection and decision-making across various industries including agriculture, healthcare, and manufacturing. By decentralizing diagnostics, the team aims to prevent pathogen impacts and ensure global supply chain resiliency.
Headquarters
Alameda, California, United States
Company Size
51-200 employees
Founded
2015
Alveo Technologies develops a portable, palm-sized molecular detection platform that brings rapid, accurate pathogen testing to the point of need across multiple sectors, including animal health, agriculture, food safety, bioindustrial, and human public health. Their system — comprising an analyzer, preloaded test cartridges, and a smartphone app — delivers molecular-grade results in under one hour without requiring specialized lab training or infrastructure. Alveo serves partners across poultry, livestock, crop, food & beverage, and public health fields, enabling early, actionable detection to protect global health, food security, and supply chain resilience.
Alveo Technologies and Global Animal Health Partner to Deploy National-Scale Molecular Avian Influenza Surveillance Across Egypt
Dec 18, 2025
Alveo Technologies Successfully Fulfills Expanded CDC Milestone Agreement to Advance its Rapid Molecular Test for both Seasonal and Avian Influenza A(H5) in Humans
Aug 26, 2025
Alveo Technologies Welcomes Nobel Laureate to its Board
Apr 30, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alveo Technologies.
120% above the average for this role
Alveo Technologies and Royal GD To Expand Poultry Testing Portfolio Beyond Avian Influenza
Jul 24, 2025